Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimen

Published:2012-12 Issue:12 Volume:36 Page:1517-1520
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Liew Elena,Atenafu Eshetu G.,Schimmer Aaron D.,Yee Karen W.L.,Schuh Andre C.,Minden Mark D.,Gupta Vikas,Brandwein Joseph M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference24 articles.

1. Treatment of adult acute lymphoblastic leukemia;Gokbuget;Semin Hematol,2009

2. Treatment of acute lymphoblastic leukemia;Pui;N Engl J Med,2006

3. Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy;Thomas;Cancer,1999

4. Medical Research Council of the United Kingdom Adult ALL Working Party. Eastern Cooperative Oncology Group. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study;Fielding;Blood,2007

5. Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial;Tavernier;Leukemia,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease;Leukemia;2023-08-28

2. The Historical Relationship Between Meis1 and Leukemia;Advances in Experimental Medicine and Biology;2022

3. Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic Programs;Cancer Discovery;2020-02-21

4. Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia;Molecular Biology Reports;2019-02

5. Defined, serum/feeder-free conditions for expansion and drug screening of primary B-acute lymphoblastic leukemia;Oncotarget;2017-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3